尔康制药：11月27日召开董事会会议

Group 1 - The core point of the article is that Erkang Pharmaceutical announced the convening of its sixth second board meeting on November 27, 2025, to discuss the reappointment of the auditing institution for 2025 [1] - For the first half of 2025, Erkang Pharmaceutical's revenue composition is as follows: 79.38% from the pharmaceutical industry, 18.57% from the new energy sector, and 2.05% from other businesses [1] - As of the time of reporting, Erkang Pharmaceutical has a market capitalization of 8.2 billion yuan [1]